4th Quarter - Amendment

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$750,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 22, 2018 $750,000 Replaced
4th Quarter - Amendment (this page) Sep 14, 2020 $750,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Accounting ACC

Importation - Affordable and Safe Prescription Drug Importation Act- Sanders

LobbyistCovered position, as disclosed
JONATHAN REA MCPHERSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Consumer Issues/Safety/Products CSP

Anti-Counterfeiting; S.469 - The Affordable and Safe Drug Importation Act

LobbyistCovered position, as disclosed
JONATHAN REA MCPHERSON —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 469 (115th)

Animals ANI

Animal Health - The Animal Drug User Fee Act of 2003 (ADUFA),

LobbyistCovered position, as disclosed
MARY BRIDGET WALSH New Sen. Bill Nelson - Legislative Assistant, Deputy Legislative Director; Sen. Jon Tester - Legislative Director, Deputy Chief of Staff and Acting Chief of Staff

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Cost Sharing (Preserving Access to Medicines); S. Amendment 178; to S. Con. Res. 3 and HR/245 & S.469 House & Senate bills titled the Affordable Safe and Prescription Drug Importation Act. Resolution expressing support for the designation of November 9, 2017 as "National Diabetes Heart Connection Awareness Day."

LobbyistCovered position, as disclosed
JONATHAN REA MCPHERSON —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 469 (115th), S.Con.Res. 3 (115th)

Medicare/Medicaid MMM

Average Sales Price; Reimbursement; CMS Rule coding for Biosimilars; IPAB (Independent Payment Advisory Board). Biosimilars and the Part D Coverage Gap Discount.

LobbyistCovered position, as disclosed
JONATHAN REA MCPHERSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

House & Senate Budget Bills; Rebates for Dual Eligible and Low Income Subsidy Populations in Medicare Part D; Non-Interference; and Drug Pricing. HR. 849 Protecting Seniors' Access to Medicare Act of 2017 (IPAB) Medicare S. Con. Res. 3 - 2017 Budget President's 2018 Budget Blue Print

LobbyistCovered position, as disclosed
JONATHAN REA MCPHERSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 849 (115th), S.Con.Res. 3 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.